Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 2, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF), announces that the Board of Directors has granted options to purchase 2,694,000...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 1, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that the Company will be presenting at the 2015 Global Chinese...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 25, 2015) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) announced today the closing of its previously announced non-brokered...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 24, 2015) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA) (OTCQB:DMCAF), announces that, subject to TSX Venture Exchange ("TSXV") approval,...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 9, 2015) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA) (OTCQB:DMCAF), announces that, subject to TSX Venture Exchange ("TSXV") approval,...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 4, 2015) - DiaMedica Inc. (TSX VENTURE:DMA) (OTCQB:DMCAF) a clinical-stage biotechnology company focused on developing novel protein...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 29, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company"), today announced the appointment of Mr. Ed Rady as the Company's...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 23, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company"), a clinical stage biopharmaceutical company focused on developing...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 21, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) (the "Company"), a biopharmaceutical company focused on developing innovative...
-
MINNEAPOLIS, MINNESOTA--(Marketwired - Sept. 24, 2015) - DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF), today announced that Rick Pauls, President and CEO, is scheduled to present at the...